Reinforcement of intestinal epithelial barrier by arabinoxylans in overweight and obese subjects: A randomized controlled trial: Arabinoxylans in gut barrier

Clinical Nutrition

Volumn 37, Issue 2, 2018, Pages 471-480

  Salden, Bouke N ^a   Troost, Freddy J ^a   Wilms, Ellen ^a   Truchado, Pilar ^b   Vilchez Vargas, Ramiro ^c   Pieper, Dietmar H ^d   Jáuregui, Ruy ^d   Marzorati, Massimo ^b   van de Wiele, Tom ^b   Possemiers, Sam ^b   Masclee, Ad A ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GHENT UNIVERSITY   (Belgium)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Arabinoxylans; Gut barrier; Gut microbiota; Obesity; Prebiotics

Indexed keywords

ACETIC ACID; ARABINOXYLAN; BUTYRIC ACID; CLAUDIN 3; CLAUDIN 4; CYTOKINE; OCCLUDIN; PROPIONIC ACID; XYLAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; FEMALE; FERMENTATION; GENETIC TRANSCRIPTION; HUMAN; IMMUNE RESPONSE; INTESTINE EPITHELIUM; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; MALE; MICROBIAL DIVERSITY; OBESITY; PARALLEL DESIGN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERMEABILITY BARRIER; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REINFORCEMENT; SIGMOID; TIGHT JUNCTION; UPREGULATION; ADOLESCENT; BLOOD; COMPLICATION; DRUG EFFECT; FECES; INTESTINE MUCOSA; MICROBIOLOGY; MIDDLE AGED; PERMEABILITY; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DOUBLE-BLIND METHOD; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PERMEABILITY; XYLANS; YOUNG ADULT;

EID: 85012883235     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2017.01.024     Document Type: Article

References (31)

1. Viggiano, D., Ianiro, G., Vanella, G., Bibbo, S., Bruno, G., Simeone, G., et al. Gut barrier in health and disease: focus on childhood. Eur Rev Med Pharmacol Sci 19:6 (2015), 1077–1085.
2. Guinane, C.M., Cotter, P.D., Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Ther Adv Gastroenterol 6:4 (2013), 295–308.
3. Cani, P.D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58:8 (2009), 1091–1103.
4. Hotamisligil, G.S., Erbay, E., Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 8:12 (2008), 923–934.
5. Gibson, G.R., Roberfroid, M.B., Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125:6 (1995), 1401–1412.
6. Grootaert, C., Van den Abbeele, P., Marzorati, M., Broekaert, W.F., Courtin, C.M., Delcour, J.A., et al. Comparison of prebiotic effects of arabinoxylan oligosaccharides and inulin in a simulator of the human intestinal microbial ecosystem. FEMS Microbiol Ecol 69:2 (2009), 231–242.
7. Hughes, S.A., Shewry, P.R., Li, L., Gibson, G.R., Sanz, M.L., Rastall, R.A., In vitro fermentation by human fecal microflora of wheat arabinoxylans. J Agric food Chem 55:11 (2007), 4589–4595.
8. Monobe, M., Ema, K., Kato, F., Maeda-Yamamoto, M., Immunostimulating activity of a crude polysaccharide derived from green tea (Camellia sinensis) extract. J Agric food Chem 56:4 (2008), 1423–1427.
9. Neyrinck, A.M., Possemiers, S., Druart, C., Van de Wiele, T., De Backer, F., Cani, P.D., et al. Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PloS one, 6(6), 2011, e20944.
10. Chen, H., Wang, W., Degroote, J., Possemiers, S., Chen, D., De Smet, S., et al. Arabinoxylan in wheat is more responsible than cellulose for promoting intestinal barrier function in weaned male piglets. J Nutr 145:1 (2015), 51–58.
11. Van den Abbeele, P., Venema, K., Van de Wiele, T., Verstraete, W., Possemiers, S., Different human gut models reveal the distinct fermentation patterns of Arabinoxylan versus inulin. J Agric Food Chem 61:41 (2013), 9819–9827.
12. Van den Abbeele, P., Gerard, P., Rabot, S., Bruneau, A., El Aidy, S., Derrien, M., et al. Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats. Environ Microbiol 13:10 (2011), 2667–2680.
13. Mujagic, Z., Ludidi, S., Keszthelyi, D., Hesselink, M.A., Kruimel, J.W., Lenaerts, K., et al. Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to confounders. Alimentary Pharmacol Ther 40:3 (2014), 288–297.
14. van Wijck, K., van Eijk, H.M., Buurman, W.A., Dejong, C.H., Lenaerts, K., Novel analytical approach to a multi-sugar whole gut permeability assay. J Chromatogr B Anal Technol Biomed Life Sci 879:26 (2011), 2794–2801.
15. Pijls, K.E., Koek, G.H., Elamin, E.E., de Vries, H., Masclee, A.A., Jonkers, D.M., Large intestine permeability is increased in patients with compensated liver cirrhosis. Am J Physiol Gastrointest Liver Physiol 306:2 (2014), G147–G153.
16. Keszthelyi, D., Troost, F.J., Jonkers, D.M., van Eijk, H.M., Lindsey, P.J., Dekker, J., et al. Serotonergic reinforcement of intestinal barrier function is impaired in irritable bowel syndrome. Alimentary Pharmacol Ther 40:4 (2014), 392–402.
17. Verstraelen, H., Vilchez-Vargas, R., Desimpel, F., Jauregui, R., Vankeirsbilck, N., Weyers, S., et al. Characterisation of the human uterine microbiome in non-pregnant women through deep sequencing of the V1-2 region of the 16S rRNA gene. PeerJ, 4, 2016, e1602.
18. Possemiers, S., Verthe, K., Uyttendaele, S., Verstraete, W., PCR-DGGE-based quantification of stability of the microbial community in a simulator of the human intestinal microbial ecosystem. FEMS Microbiol Ecol 49:3 (2004), 495–507.
19. Bremner, J.M., Keeney, D.R., Steam distillation methods for determination of ammonium, nitrate and nitrite. Anal Chem Acta 32 (1965), 485–495.
20. Svedlund, J., Sjodin, I., Dotevall, G., GSRS–a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 33:2 (1988), 129–134.
21. Kim, H., Bartley, G.E., Young, S.A., Davis, P.A., Yokoyama, W., HPMC supplementation reduces abdominal fat content, intestinal permeability, inflammation, and insulin resistance in diet-induced obese mice. Mol Nutr food Res 56:9 (2012), 1464–1476.
22. Teixeira, T.F., Souza, N.C., Chiarello, P.G., Franceschini, S.C., Bressan, J., Ferreira, C.L., et al. Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clin Nutr 31:5 (2012), 735–740.
23. Brignardello, J., Morales, P., Diaz, E., Romero, J., Brunser, O., Gotteland, M., Pilot study: alterations of intestinal microbiota in obese humans are not associated with colonic inflammation or disturbances of barrier function. Alimentary Pharmacol Ther 32:11–12 (2010), 1307–1314.
24. Xiao, S., Fei, N., Pang, X., Shen, J., Wang, L., Zhang, B., et al. A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiol Ecol 87:2 (2014), 357–367.
25. Canani, R.B., Costanzo, M.D., Leone, L., Pedata, M., Meli, R., Calignano, A., Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 17:12 (2011), 1519–1528.
26. Lecerf, J.M., Depeint, F., Clerc, E., Dugenet, Y., Niamba, C.N., Rhazi, L., et al. Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. Br J Nutr 108:10 (2012), 1847–1858.
27. van Dokkum, W., Wezendonk, B., Srikumar, T.S., van den Heuvel, E.G., Effect of nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects. Eur J Clin Nutr 53:1 (1999), 1–7.
28. Slavin, J., Feirtag, J., Chicory inulin does not increase stool weight or speed up intestinal transit time in healthy male subjects. Food Funct 2:1 (2011), 72–77.
29. Goldberg, R.B., Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 94:9 (2009), 3171–3182.
30. Lu, Z.X., Walker, K.Z., Muir, J.G., O'Dea, K., Arabinoxylan fibre improves metabolic control in people with Type II diabetes. Eur J Clin Nutr 58:4 (2004), 621–628.
31. Macfarlane, G.T.G.G., Microbiological aspects of production of short-chain fatty acids in the large bowel. 1999, Cambridge University Press, Cambridge.